Contributor Page
Lucas & Co
 
Email  |  Articles
Contact Details
Tel: +44 1883 626211
Fax: +44 1883 622997
135 Westhall Road
Warlingham
Surrey
CR6 9HJ
UK
By Paul Cole
Kirin-Amgen Inc ("Amgen"), a Californian pharmaceutical company, is the proprietor of EP-B- 0148605 relating to the production of erythropoietin ("EPO") by recombinant DNA technology. EPO is a hormone made in the kidney that stimulates the production of red blood cells by the bone marrow. Amgen had sequenced the EPO gene and its leader sequence, which was essential to any method of making erythropoietin and which was disclosed in their patent.
By Paul Cole
This discussion is with particular, but not exclusive, reference to practice in the pharmaceutical industry for claiming new chemical entities, and in particular to the feasibility of defining a genus of compounds that validly covers compounds that have not yet been made and tested.
By Paul Cole
Will potential licensees and competitors respect a patent and will it survive opposition, revocation or infringement proceedings?
By Paul Cole
Will potential licensees and competitors respect a patent and will it survive opposition, revocation or infringement proceedings?
By Paul Cole
By Paul Cole, Paul Cole
By Paul Cole
By Paul Cole, Paul Cole
By Paul Cole, Paul Cole
By Paul Cole